Comparison
2q24 Microdeletion Syndrome vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between 2q24 Microdeletion Syndrome and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
2q24 Microdeletion Syndrome
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
2q24 Microdeletion Syndrome
0-1
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
2q24 Microdeletion Syndrome
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
2q24 Microdeletion Syndrome
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
2q24 Microdeletion Syndrome
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
2q24 Microdeletion Syndrome
congenital
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
2q24 Microdeletion Syndrome
rare-disease
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
2q24-microdeletion-syndrome-C2931816 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q24 Microdeletion Syndrome | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Developmental delay | May begin in the first year; severity is not established from supplied data. | May appear by age 3, often with learning difficulty. | Low |
| Neurobehavioral features | Specific behavioral pattern is not established here. | Autism-spectrum traits are sometimes reported. | Moderate |
| Overall clinical severity | Supplied axis rates severity as severe. | Supplied axis rates severity as moderate. | Moderate |
When to favor each condition
Choose 2q24 Microdeletion Syndrome when
Infant with congenital findings and a confirmed 2q24 deletion
The chromosomal result, not symptoms alone, identifies this condition.
High
Early severe presentation before age 1
Fits the supplied onset and severity axes, but is not diagnostic.
Low
Genetic report specifies deletion rather than duplication
Copy-number direction distinguishes the two entities.
High
Choose 15q11q13 Microduplication Syndrome C2675336 when
Confirmed duplication of 15q11q13
Laboratory localization and duplication establish this diagnosis.
High
Developmental delay with learning difficulty or autism-spectrum traits
Matches the supplied description but requires genetic confirmation.
Moderate
Presentation between birth and age 3 with moderate impact
Consistent with supplied axes, not sufficient alone.
Low
How key tests differ
| Test | 2q24 Microdeletion Syndrome | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion involving 2q24 if present. | Duplication involving 15q11q13 if present. | The locus and copy-number change distinguish them; clinician review is required. |
| Karyotype | May miss a small deletion. | May miss a small duplication. | A normal karyotype does not exclude either condition. |
| Clinical examination | No definitive pattern is established here. | May show developmental or learning concerns. | Examination supports evaluation but cannot replace genetic testing. |
Prognosis comparison
2q24 Microdeletion Syndrome
- Outcome
- A chronic course is indicated, but individual outcome is not established.
- Factors
- Supplied data cite severe severity and infantile onset only.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- Often managed supportively; outcome varies and is not quantified here.
- Factors
- Developmental, learning, and behavioral features may influence needs.
Time frame: Lifelong follow-up is generally relevant; exact milestones are not established.
Chromosomal result, associated findings, therapies, and comorbidities require clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning and developmental needs | Potentially substantial, but exact burden is not established. Learning difficulty and developmental delay may occur. Needs vary; individualized developmental assessment is appropriate. |
| Neurobehavioral concerns | Not specifically established from supplied data. Autism-spectrum traits are sometimes described. Behavioral evaluation should be guided by the child, not assumed. |
| Long-term medical complexity | Severe chronic course is suggested by supplied axes. Moderate chronic course is suggested. Neither axis predicts complications for an individual. |
Patient education highlights
- HighGenetic confirmation
Symptoms overlap; the specific chromosomal result determines which condition applies.
- HighSupportive care
Therapies and educational support are tailored; no dose or treatment protocol is implied here.
- MediumFamily counseling
Inheritance and recurrence require genetics counseling and cannot be inferred from this comparison.